Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8835930rdf:typepubmed:Citationlld:pubmed
pubmed-article:8835930lifeskim:mentionsumls-concept:C0034721lld:lifeskim
pubmed-article:8835930lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:8835930lifeskim:mentionsumls-concept:C0015677lld:lifeskim
pubmed-article:8835930lifeskim:mentionsumls-concept:C0021853lld:lifeskim
pubmed-article:8835930lifeskim:mentionsumls-concept:C0000854lld:lifeskim
pubmed-article:8835930lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:8835930lifeskim:mentionsumls-concept:C2757059lld:lifeskim
pubmed-article:8835930lifeskim:mentionsumls-concept:C0058897lld:lifeskim
pubmed-article:8835930pubmed:issue1lld:pubmed
pubmed-article:8835930pubmed:dateCreated1997-3-3lld:pubmed
pubmed-article:8835930pubmed:abstractTextEbelactones A and B, natural products from Streptomyces aburaviensis are potent inhibitors of pancreatic lipase. Lipase is the key enzyme required for the absorption of dietary triglycerides (TG). Ebelactone B inhibited, in a dose-dependent manner, the intestinal absorption of fat after fat-feeding in the rat. The most effective inhibition was observed when the inhibitor was administered at 60 min prior to fat-feeding. When ebelactone B (10 mg/kg) was administered, the serum levels of TG (58%) and cholesterol (36%) were decreased. Since ebelactone B effectively inhibitors absorption of dietary fat, if may provide a promising means for prophylaxis or therapeutics of hyperlipidemia and obesity.lld:pubmed
pubmed-article:8835930pubmed:languageenglld:pubmed
pubmed-article:8835930pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8835930pubmed:citationSubsetIMlld:pubmed
pubmed-article:8835930pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8835930pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8835930pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8835930pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8835930pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8835930pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8835930pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8835930pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8835930pubmed:statusMEDLINElld:pubmed
pubmed-article:8835930pubmed:issn8755-5093lld:pubmed
pubmed-article:8835930pubmed:authorpubmed-author:AoyagiTTlld:pubmed
pubmed-article:8835930pubmed:authorpubmed-author:OhtsukaEElld:pubmed
pubmed-article:8835930pubmed:authorpubmed-author:TakeuchiTTlld:pubmed
pubmed-article:8835930pubmed:authorpubmed-author:FukudaTTlld:pubmed
pubmed-article:8835930pubmed:authorpubmed-author:NonakaYYlld:pubmed
pubmed-article:8835930pubmed:authorpubmed-author:OhtakiHHlld:pubmed
pubmed-article:8835930pubmed:authorpubmed-author:KochaTTlld:pubmed
pubmed-article:8835930pubmed:issnTypePrintlld:pubmed
pubmed-article:8835930pubmed:volume10lld:pubmed
pubmed-article:8835930pubmed:ownerNLMlld:pubmed
pubmed-article:8835930pubmed:authorsCompleteYlld:pubmed
pubmed-article:8835930pubmed:pagination57-63lld:pubmed
pubmed-article:8835930pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:8835930pubmed:meshHeadingpubmed-meshheading:8835930-...lld:pubmed
pubmed-article:8835930pubmed:meshHeadingpubmed-meshheading:8835930-...lld:pubmed
pubmed-article:8835930pubmed:meshHeadingpubmed-meshheading:8835930-...lld:pubmed
pubmed-article:8835930pubmed:meshHeadingpubmed-meshheading:8835930-...lld:pubmed
pubmed-article:8835930pubmed:meshHeadingpubmed-meshheading:8835930-...lld:pubmed
pubmed-article:8835930pubmed:meshHeadingpubmed-meshheading:8835930-...lld:pubmed
pubmed-article:8835930pubmed:meshHeadingpubmed-meshheading:8835930-...lld:pubmed
pubmed-article:8835930pubmed:meshHeadingpubmed-meshheading:8835930-...lld:pubmed
pubmed-article:8835930pubmed:meshHeadingpubmed-meshheading:8835930-...lld:pubmed
pubmed-article:8835930pubmed:meshHeadingpubmed-meshheading:8835930-...lld:pubmed
pubmed-article:8835930pubmed:meshHeadingpubmed-meshheading:8835930-...lld:pubmed
pubmed-article:8835930pubmed:meshHeadingpubmed-meshheading:8835930-...lld:pubmed
pubmed-article:8835930pubmed:meshHeadingpubmed-meshheading:8835930-...lld:pubmed
pubmed-article:8835930pubmed:meshHeadingpubmed-meshheading:8835930-...lld:pubmed
pubmed-article:8835930pubmed:meshHeadingpubmed-meshheading:8835930-...lld:pubmed
pubmed-article:8835930pubmed:meshHeadingpubmed-meshheading:8835930-...lld:pubmed
pubmed-article:8835930pubmed:year1996lld:pubmed
pubmed-article:8835930pubmed:articleTitleEffects of ebelactone B, a lipase inhibitor, on intestinal fat absorption in the rat.lld:pubmed
pubmed-article:8835930pubmed:affiliationShowa College of Pharmaceutical Science, Tokyo, Japan.lld:pubmed
pubmed-article:8835930pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8835930lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8835930lld:pubmed